Polymorphic Post-transplant Lymphoproliferative Disorder
📧 Sign up to get email alerts when something new happens for Polymorphic Post-transplant Lymphoproliferative Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder [Phase 2]
A Phase 2 clinical trial evaluating front-line Tafasitamab with Rituximab for monomorphic and polymorphic post-transplant lymphoproliferativ…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma [Phase 2]
A Phase 2 trial update from Northwestern University evaluating the combination of epcoritamab and lenalidomide in patients with refractory o…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders [Phase 1]
Phase 1 trial update for Epcoritamab in relapsed or refractory post-transplant lymphoproliferative disorders, including DLBCL-type PTLD and …